Corrigendum to “Optimization and Corroboration of the Regulatory Pathway of p42.3 Protein in the Pathogenesis of Gastric Carcinoma”

by Yibin Hao, Tianli Fan, Kejun Nan
Published 2015-01-01

Establishment of apoptotic regulatory network for genetic markers of colorectal cancer

by Yibin Hao, Guoyong Shan, Kejun Nan
Published 2017-03-01

Optimization and Corroboration of the Regulatory Pathway of p42.3 Protein in the Pathogenesis of Gastric Carcinoma

by Yibin Hao, Tianli Fan, Kejun Nan
Published 2015-01-01

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma

by Luochengling Xiang, Xiao Fu, Xiao Wang, Wenyuan Li, Xiaoqiang Zheng, Kejun Nan, Kejun Nan, Tao Tian
Published 2020-09-01

Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients

by Yiyang Bai, Xiao Wang, Jia Hou, Luying Geng, Xuan Liang, Zhiping Ruan, Hui Guo, Kejun Nan, Kejun Nan, Lili Jiang
Published 2020-08-01

Establishment of optimal regulatory network of colorectal cancer based on p42.3 protein

by Yibin Hao, Jianhua Zhang, Guoyong Shan, Ning Zhang, Wenwen Jin, Kejun Nan
Published 2017-12-01

High Skp2/Low p57Kip2 Expression is Associated with Poor Prognosis in Human Breast Carcinoma

by Chengcheng Yang, Haocheng Nan, Jiequn Ma, Lili Jiang, Qianqian Guo, Lili Han, Yamin Zhang, Kejun Nan, Hui Guo
Published 2015-08-01

High Skp2/Low p57 Expression is Associated with Poor Prognosis in Human Breast Carcinoma

by Chengcheng Yang, Haocheng Nan, Jiequn Ma, Lili Jiang, Qianqian Guo, Lili Han, Yamin Zhang, Kejun Nan, Hui Guo
Published 2015-01-01

Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway

by Tianhe Huang, Fuling Zhou, Xiaohan Yuan, Tian Yang, Xuan Liang, Yu Wang, Honglei Tu, Jiantong Chang, Kejun Nan, Yongchang Wei
Published 2019-01-01

Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway

by Xiao Fu, Mengjie Liu, Shengyang Qu, Jiequn Ma, Yamin Zhang, Tingting Shi, Hongqing Wen, Yujuan Yang, Shuhong Wang, Jing Wang, Kejun Nan, Yu Yao, Tao Tian
Published 2018-03-01

Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial...

by Ying Cheng, Baohui Han, Kai Li, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Jing Zhu
Published 2020-04-01

Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303

by Xiaoyan Si, Li Zhang, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin
Published 2019-03-01

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

by Jing Wang, Yizhuo Zhao, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Hao Yu, Yang Zhao, Weiqiang Chen, Yi Luo, Xiuwen Wang, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, Zhujun Liu, Baohui Han, Kai Li
Published 2018-12-01

Occurrence of hypertension during third‐line anlotinib is associated with progression‐free survival in patients with squamous cell lung cancer (SCC): A post hoc analysis of the ALT...

by Jianhua Shi, Guimin Chen, Haitao Wang, Xiuxiu Wang, Baohui Han, Kai Li, Qiming Wang, Li Zhang, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Yi Luo, Lin Wu, Xiuwen Wang, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, Zhian Liu
Published 2021-09-01